Testing effectiveness (Phase 2)UnknownNCT03869944What this trial is testingPreventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEVWho this might be right forHIV-1 ANRS, Emerging Infectious Diseases 97
Not applicableLooking for participantsNCT05897099What this trial is testingComprehensive HIV and Harm Prevention Via TelehealthWho this might be right forHIV Infections University of Miami 350
Post-approval studies (Phase 4)Ended earlyNCT02322099What this trial is testingAlendronate for Prevention of AntiRetroviral Therapy-associated Bone LossWho this might be right forBone Demineralization University College Dublin 53
Testing effectiveness (Phase 2)Study completedNCT00643305What this trial is testingHIV Prevention With the Mentally IllWho this might be right forHIV Infections Boston Medical Center 53
Early research (Phase 1)WithdrawnNCT02245945What this trial is testingSafety and Acceptability of Tenofovir 1% Gel in Adolescent FemalesWho this might be right forHIV Prevention CONRAD
Not applicableStudy completedNCT01632995What this trial is testingAssessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) ClinicsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 557
Not applicableActive Not RecruitingNCT03981445What this trial is testingIntegrated HIV Prevention and HCV Care for PWIDWho this might be right forHIV PreventionHCVOpioid Use+1 more Columbia University 446
Not applicableStudy completedNCT03411577What this trial is testingDevelopment and Testing of a Jamaican Mother-daughter HIV Risk-reduction ProgramWho this might be right forParent-Child RelationsHIV PreventionAdolescent Behavior Boston College 662
Not applicableStudy completedNCT00393575What this trial is testingC2P Mobilization Intervention (Pilot)Who this might be right forHIV Infections University of North Carolina, Chapel Hill 15
Not applicableLooking for participantsNCT07246057What this trial is testingStreamlining Telehealth for Expanded PrEP Utilization Through Community PartnershipsWho this might be right forHIV University of Pennsylvania 92
Post-approval studies (Phase 4)Study completedNCT01618305What this trial is testingEvaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child TransmissionWho this might be right forHIV Infections Westat 408
Large-scale testing (Phase 3)Study completedNCT00619320What this trial is testingReducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing WomenWho this might be right forHIV InfectionsSubstance Use Virginia Commonwealth University 380
Not applicableEnrolling By InvitationNCT06334341What this trial is testingA Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP)Who this might be right forHIV Seropositivity Henry Ford Health System 1,380
Early research (Phase 1)Ended earlyNCT00623753What this trial is testingEvaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy AdultsWho this might be right forHIV Infections St. Jude Children's Research Hospital 3
Not applicableStudy completedNCT03459157What this trial is testingAccess to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)Who this might be right forHIV/AIDS ANRS, Emerging Infectious Diseases 649
Testing effectiveness (Phase 2)Study completedNCT01690442What this trial is testingHIV Prevention for Injecting Drug Users in KazakhstanWho this might be right forHIVAIDS Columbia University 600
Not applicableStudy completedNCT00001077What this trial is testingA Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral SupplementsWho this might be right forHIV InfectionsHIV Wasting Syndrome National Institute of Allergy and Infectious Diseases (NIAID) 536
Not applicableStudy completedNCT02263391What this trial is testingHIV Risk and Prevention in WomenWho this might be right forHIV University of Oklahoma 200
Very early researchStudy completedNCT03197961What this trial is testingPharmacokinetics and Pharmacodynamics of DMPA With HIV PrEPWho this might be right forHIV/AIDSContraception Sharon Achilles 15
Large-scale testing (Phase 3)Looking for participantsNCT07071623What this trial is testingMK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)Who this might be right forHuman Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis Merck Sharp & Dohme LLC 4,580